BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Public ClinicalTrials.gov record NCT00751530. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Outcomes of Early Raltegravir Experience: Comparison of Virologic Response in Regimens Not Containing a Protease Inhibitor in the Antiretroviral Background Regimen Versus a Protease Inhibitor in the Background Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a retrospective chart review of participants in raltegravir expanded access program and will compare virologic response in regimens not containing a protease inhibitor in the antiretroviral background regimen to regimens containing a protease inhibitor in the background regimen.
Study identification
- NCT ID
- NCT00751530
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 442 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2008
- Primary completion
- Jun 14, 2009
- Completion
- Jun 14, 2009
- Last update posted
- Jul 1, 2017
2008 – 2009
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Light Source Medical | Los Angeles | California | 900036 | — |
| AIDS Healthcare Foundation | Los Angeles | California | 90028 | — |
| Synergy Hematology and Oncology | Los Angeles | California | 90036 | — |
| Quest Clinical Research | San Francisco | California | 94115 | — |
| Connecticut Health Care Group | Glastonbury | Connecticut | 06033 | — |
| Dupont Circle Physicians Group | Washington D.C. | District of Columbia | 20009 | — |
| Capital Medical Associates PC | Washington D.C. | District of Columbia | 20036 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Ruth M. Rothstein CORE Center | Chicago | Illinois | 60612 | — |
| Community Research Initiative | Boston | Massachusetts | 02215 | — |
| Community Research Initiative - West | Springfield | Massachusetts | 01107 | — |
| Infectious Diseases and HIV Medicine Immunodeficiency Clinic | Buffalo | New York | 14215 | — |
| Bellman, MD | New York | New York | 10003 | — |
| Mounzer, MD | Philadelphia | Pennsylvania | 19107 | — |
| Dr. Nicholaos C. Bellos & Associates | Dallas | Texas | 75204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00751530, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00751530 live on ClinicalTrials.gov.